This process, known as blastocyst complementation, involves injecting rat stem cells into mouse blastocysts—early-stage embryos lacking the ability to develop a pancreas due to genetic mutations.

targeting the Kirsten Rat Sarcoma Viral Oncogene Homolog glycine 12 mutated to valine (KRAS G12V) mutation in individuals with advanced pancreatic cancer. VIDAR-1 is specifically structured to ...